DHT-UN.TO DRI HEALTHCARE TRUST
$16.95▲ +0.06%
Healthcare
Other
Volume 36.3K
Avg Volume (10D) 50.9K
Key Metrics & Fundamentals
Market Cap
$953.69M
P/E Ratio
–
Div Yield
3.53%
52W Range
14.10 - 19.75
% vs 50 MA
-5.28%
% vs 200 MA
-0.12%
RSI-14
34.9
MACD Histogram
-0.0700
Beta (1Y vs SPY)
0.72
Free Cash Flow
$33.60M
Gross Rev
$41.50M
Gross Profit
$41.50M
EBITDA
–
COGS
–
Operating Exp
$32.44M
Operating Income
–
EBIT
–
Pretax Income
$9.05M
Net Income
$6.02M
EPS (Diluted)
0.11
Price & Volume History
Loading chart…
Recent News
DRI Healthcare Announces Receipt of Put Price on EKTERLY
CNW Group · Aug 11, 2026 12:00 PM
DRI Healthcare Trust Q2 Earnings Call Highlights
MarketBeat · Aug 10, 2026 5:04 PM
DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment
CNW Group · Aug 7, 2026 9:00 PM
DRI Healthcare to Host Second Quarter 2026 Earnings Call and Webcast on August 10, 2026
CNW Group · Jul 20, 2026 9:10 PM
DRI Healthcare Trust Exercises its Put Option on EKTERLY
MT Newswires · Jul 10, 2026 2:21 PM
DRI Healthcare Announces Exercise of Put Option on EKTERLY®
CNW Group · Jul 10, 2026 1:07 PM
DRI Healthcare to Pay Viridian US$75 Million as FDA Approves Lumvoa For Thyroid Eye Disease
MT Newswires · Jun 29, 2026 11:31 AM
DRI Healthcare Comments on Viridian's FDA Approval and Launch of Lumvoa™ (veligrotug-vvze)
CNW Group · Jun 29, 2026 11:00 AM
DRI HEALTHCARE TRUST CLASS ACTION SETTLEMENT - Notice of Proposed Settlement and Opt-Out Deadline
CNW Group · Jun 19, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See DHT-UN.TO's money flow as a full page
Social Sentiment
No Reddit posts found for DHT-UN.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.